AAAAAA

   
Results: 1-7 |
Results: 7
THE EFFECT OF SOY ISOFLAVONES ON THE DEVELOPMENT OF INTESTINAL NEOPLASIA IN APC(MIN) MOUSE
Authors: SORENSEN IK KRISTIANSEN E MORTENSEN A NICOLAISEN GM WIJNANDES JAH VANKRANEN HJ VANKREIJL CF
Citation: Ik. Sorensen et al., THE EFFECT OF SOY ISOFLAVONES ON THE DEVELOPMENT OF INTESTINAL NEOPLASIA IN APC(MIN) MOUSE, Cancer letters, 130(1-2), 1998, pp. 217-225
EFFECTS OF LONG-TERM FEEDING WITH 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) IN C57BL BYA AND E-MU-PIM-1 MICE/
Authors: KRISTIANSEN E MORTENSEN A SORENSEN IK
Citation: E. Kristiansen et al., EFFECTS OF LONG-TERM FEEDING WITH 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) IN C57BL BYA AND E-MU-PIM-1 MICE/, Cancer letters, 122(1-2), 1998, pp. 215-220
SHORT-TERM CARCINOGENICITY TESTING OF A POTENT MURINE INTESTINAL MUTAGEN, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE (PHIP), IN APC1638N TRANSGENIC MICE
Authors: SORENSEN IK KRISTIANSEN E MORTENSEN A VANKRANEN H VANKREIJL C FODDE R THORGEIRSSON SS
Citation: Ik. Sorensen et al., SHORT-TERM CARCINOGENICITY TESTING OF A POTENT MURINE INTESTINAL MUTAGEN, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE (PHIP), IN APC1638N TRANSGENIC MICE, Carcinogenesis, 18(4), 1997, pp. 777-781
SHORT-TERM CARCINOGENICITY TESTING OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) AND 2-AMINO-3-METHYLIMIDAZO[4,5-F] QUINOLINE (IQ) IN E-MU-PIM-1 TRANSGENIC MICE
Authors: SORENSEN IK MORTENSEN A KRISTIANSEN E VANKREIJL C ADAMSON RH THORGEIRSSON SS
Citation: Ik. Sorensen et al., SHORT-TERM CARCINOGENICITY TESTING OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) AND 2-AMINO-3-METHYLIMIDAZO[4,5-F] QUINOLINE (IQ) IN E-MU-PIM-1 TRANSGENIC MICE, Carcinogenesis, 17(10), 1996, pp. 2221-2227
A REPORT PREPARED FOR THE EEC ON THE WORKSHOP - RISK-EVALUATION OF GENETICALLY-MODIFIED MICROORGANISMS IN RELATION TO HUMAN HEALTH, COPENHAGEN, 10-13 NOVEMBER 1992 - INTRODUCTION
Authors: JACOBSEN BB KNUDSEN IB SCHLUNDT J SORENSEN IK
Citation: Bb. Jacobsen et al., A REPORT PREPARED FOR THE EEC ON THE WORKSHOP - RISK-EVALUATION OF GENETICALLY-MODIFIED MICROORGANISMS IN RELATION TO HUMAN HEALTH, COPENHAGEN, 10-13 NOVEMBER 1992 - INTRODUCTION, Microbial ecology in health and disease, 8, 1995, pp. 5-6
WORKING GROUP-V - RABIES RECOMBINANT VACCINE AS AN EXAMPLE OF WHAT MIGHT BE REQUIRED BY REGULATORY AUTHORITIES
Authors: BERKOWITZ D BISHOP D PASTORET PP PERVIKOV Y SMITH H SORENSEN IK
Citation: D. Berkowitz et al., WORKING GROUP-V - RABIES RECOMBINANT VACCINE AS AN EXAMPLE OF WHAT MIGHT BE REQUIRED BY REGULATORY AUTHORITIES, Microbial ecology in health and disease, 8, 1995, pp. 37-40
WORKING GROUP-VI - REPORT FROM THE WORKSHOP ON GENETICALLY-MODIFIED VACCINES
Authors: BERKOWITZ D CONTREPOIS M DEGREVE H GUNDERSEN WB HOFFJORGENSEN R KLEM P KROGFELDT KA LINTERMANNS P MORTENSEN S PERVIKOV Y SMITH H SORENSEN IK VUUST J
Citation: D. Berkowitz et al., WORKING GROUP-VI - REPORT FROM THE WORKSHOP ON GENETICALLY-MODIFIED VACCINES, Microbial ecology in health and disease, 8, 1995, pp. 41-42
Risultati: 1-7 |